page contents

Tag Archives: Rating

Array Biopharma Inc (NASDAQ:ARRY) has coverage initiated with a Overweight rating and $30.00 price target

Array Biopharma Inc (NASDAQ:ARRY) has coverage initiated with a Overweight rating and $ 30.00 price target Jan 15, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Array Biopharma Inc (NASDAQ:ARRY) Today, Cantor Fitzgerald initiated coverage on Array Biopharma Inc (NASDAQ:ARRY) with a Overweight with a price target of $ 30.00. There are 8 Buy Ratings, 1 Hold Ratings, no ...

Read More »

Array Biopharma Inc (NASDAQ:ARRY) has coverage initiated with a Overweight rating and $30.00 price target

Array Biopharma Inc (NASDAQ:ARRY) has coverage initiated with a Overweight rating and $ 30.00 price target Jan 15, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Array Biopharma Inc (NASDAQ:ARRY) Today, Cantor Fitzgerald initiated coverage on Array Biopharma Inc (NASDAQ:ARRY) with a Overweight with a price target of $ 30.00. There are 8 Buy Ratings, 1 Hold Ratings, no ...

Read More »

ASLAN PHARMACEU/ADR (NASDAQ:ASLN) had its Buy ➝ Buy rating reiterated by HC Wainwright with a $8.50 price target

ASLAN PHARMACEU/ADR (NASDAQ:ASLN) had its Buy ➝ Buy rating reiterated by HC Wainwright with a $ 8.50 price target Jan 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For ASLAN PHARMACEU/ADR (NASDAQ:ASLN) Today, HC Wainwright reiterated its Buy rating on ASLAN PHARMACEU/ADR (NASDAQ:ASLN) with a price target of $ 8.50. There are 3 Buy Ratings, 1 Hold Ratings, no ...

Read More »

Codexis, Inc. (NASDAQ:CDXS) had its Buy rating reiterated by HC Wainwright with a $16.50 price target

Codexis, Inc. (NASDAQ:CDXS) had its Buy rating reiterated by HC Wainwright with a $ 16.50 price target Jan 14, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Codexis, Inc. (NASDAQ:CDXS) Today, HC Wainwright reiterated its Buy rating on Codexis, Inc. (NASDAQ:CDXS) with a price target of $ 16.50. There are 4 Buy Ratings, no Strong Buy Ratings, no Sell ...

Read More »

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright Jan 11, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX) Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX). There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus ...

Read More »

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright Jan 11, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX) Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX). There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus ...

Read More »

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright

Agile Therapeutics Inc (NASDAQ:AGRX) had its Buy rating reiterated by HC Wainwright Jan 11, 2019 (Market Exclusive via COMTEX) — Analyst Ratings For Agile Therapeutics Inc (NASDAQ:AGRX) Today, HC Wainwright reiterated its Buy rating on Agile Therapeutics Inc (NASDAQ:AGRX). There are 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock. The current consensus ...

Read More »

MONAT Global Receives AAA+ Rating from Business For Home

MONAT Global Receives AAA+ Rating from Business For Home MONAT(R) Global (MONAT), a multinational distributor of premium hair care products, received an AAA+ rating from Business For Home based on key criteria such as revenue, momentum, Alexa rankings, poll results, input from direct selling professionals, top earners and regularly conducted home office visits by the Business For Home team. MONAT’s ...

Read More »

MONAT Global Receives AAA+ Rating from Business For Home

MONAT Global Receives AAA+ Rating from Business For Home MONAT(R) Global (MONAT), a multinational distributor of premium hair care products, received an AAA+ rating from Business For Home based on key criteria such as revenue, momentum, Alexa rankings, poll results, input from direct selling professionals, top earners and regularly conducted home office visits by the Business For Home team. MONAT’s ...

Read More »

MONAT Global Receives AAA+ Rating from Business For Home

MONAT Global Receives AAA+ Rating from Business For Home MONAT(R) Global (MONAT), a multinational distributor of premium hair care products, received an AAA+ rating from Business For Home based on key criteria such as revenue, momentum, Alexa rankings, poll results, input from direct selling professionals, top earners and regularly conducted home office visits by the Business For Home team. MONAT’s ...

Read More »

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close